Trial reportBrain and behavior2026
Effects of Transcutaneous Vagus Nerve Stimulation on Cerebral Perfusion and Cognitive Function Under Simulated High-Altitude Hypobaric Hypoxia.
Trial report in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study is to investigate the effects of hypobaric hypoxia (simulated altitude of 3600 m) on regional cerebral blood flow (CBF) and cognitive function, and to explore the regulatory role of transcutaneous vagus nerve stimulation (tVNS).
methodsForty-three healthy Han Chinese males (18-45 years) were enrolled at the Chinese PLA General Hospital (June 2024-December 2025). During 24-h hypobaric hypoxia exposure via a specialized hypobaric chamber, participants were randomly assigned to tVNS (n = 23) or non-tVNS (n = 20) groups. A non-exposure cohort (n = 18) was included to correct for cognitive learning effects. Arterial spin labeling quantified CBF in the anterior, middle, and posterior cerebral artery territories and hippocampus at baseline, exposure, and post-exposure; the Repeatable Battery for the Assessment of Neuropsychological Status assessed cognitive function at the same time points.
resultsHypoxia-induced compensatory CBF increases across all examined regions in the control group (p < 0.05). In the tVNS group, CBF modulation was region-specific: frontotemporal CBF was higher at exposure than post-exposure and higher at post-exposure than baseline; occipital and hippocampal CBF were higher at exposure than at both other time points, with no difference between post-exposure and baseline. Only temporal lobe CBF was significantly higher in the tVNS group than the control group (76.22 ± 7.49 vs. 70.88 ± 8.93, p = 0.039). Hypoxia impaired visuospatial ability, language, and attention and delayed memory (all p < 0.05), but tVNS did not ameliorate these deficits.
conclusionsSimulated 3600 m hypobaric hypoxia induces compensatory regional CBF elevations. tVNS selectively increases temporal lobe perfusion but does not ameliorate cognitive impairment, warranting optimized studies to clarify its neuroprotective role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.